-
1
-
-
0005233291
-
HAART reduces overall costs of HIV care at DVAMC-Denver
-
February, abstract 200
-
See, for example:McCollum, M, et al HAART reduces overall costs of HIV care at DVAMC-Denver. Fifth Conference on Retroviruses and Opportunistic Infections. February, 1998: abstract 200: 116.
-
(1998)
Fifth Conference on Retroviruses and Opportunistic Infections
, pp. 116
-
-
McCollum, M.1
-
2
-
-
0343332212
-
-
Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS Epidemic update: December 1998. Geneva: UNAIDS
-
Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS Epidemic update: December 1998. Geneva: UNAIDS, 1998. (www.unaids.org/highband/document/epidemio/ wadr98e/pdf)
-
(1998)
-
-
-
3
-
-
0029128834
-
Success rates for new drugs entering clinical testing in the United States
-
DiMasi JA. Success rates for new drugs entering clinical testing in the United States. Clinical Pharmacology and Therapeutics 1905;58:1-14, and: Office of Technology and Assessment. Pharmaceutical R&D: costs, risks and rewards (OTA-H-523). Washington DC: US Government Printing Office, 1996.
-
(1905)
Clinical Pharmacology and Therapeutics
, vol.58
, pp. 1-14
-
-
DiMasi, J.A.1
-
4
-
-
0029128834
-
-
Washington DC: US Government Printing Office
-
DiMasi JA. Success rates for new drugs entering clinical testing in the United States. Clinical Pharmacology and Therapeutics 1905;58:1-14, and: Office of Technology and Assessment. Pharmaceutical R&D: costs, risks and rewards (OTA-H-523). Washington DC: US Government Printing Office, 1996.
-
(1996)
Pharmaceutical R&D: Costs, Risks and Rewards (OTA-H-523)
-
-
-
5
-
-
0028003766
-
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
-
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, a al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 1994;331:1173-80.
-
(1994)
New England Journal of Medicine
, vol.331
, pp. 1173-1180
-
-
Connor, E.M.1
Sperling, R.S.2
Gelber, R.3
Kiselev, P.4
Scott, G.5
O'Sullivan, M.J.6
-
6
-
-
0033528527
-
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial
-
Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999; 353:781-5.
-
(1999)
Lancet
, vol.353
, pp. 781-785
-
-
Wiktor, S.Z.1
Ekpini, E.2
Karon, J.M.3
Nkengasong, J.4
Maurice, C.5
Severin, S.T.6
-
7
-
-
0033528521
-
Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkino Faso: A double-blind placebo-controlled multicentre trial
-
Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkino Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999; 353:768-92.
-
(1999)
Lancet
, vol.353
, pp. 768-792
-
-
Dabis, F.1
Msellati, P.2
Meda, N.3
Welffens-Ekra, C.4
You, B.5
Manigart, O.6
-
8
-
-
0033523454
-
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda.HIVNET 012 randomised trial
-
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda.HIVNET 012 randomised trial. Lancet 1999;354:795-802.
-
(1999)
Lancet
, vol.354
, pp. 795-802
-
-
Guay, L.A.1
Musoke, P.2
Fleming, T.3
Bagenda, D.4
Allen, M.5
Nakabiito, C.6
-
10
-
-
0003111077
-
Interim analysis of early efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1: The PETRA trial
-
Jan-Feb abstract S7
-
Saba J. Interim analysis of early efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1: the PETRA trial. Sixth Conference on Retroviruses and Opportunistic infections, Jan-Feb 1999; abstract S7.
-
(1999)
Sixth Conference on Retroviruses and Opportunistic Infections
-
-
Saba, J.1
-
11
-
-
0028151440
-
Mother-to-child transmission of human immunodeficiency virus type 1 - Report from the Nairobi study
-
Datta P, Embree JE, Kreiss JK, Ndinva-Achola JO, Braddick M, Temmerman M. Mother-to-child transmission of human immunodeficiency virus type 1 - report from the Nairobi study. Jounal of infectious Diseases 1994;170:1134-40.
-
(1994)
Jounal of Infectious Diseases
, vol.170
, pp. 1134-1140
-
-
Datta, P.1
Embree, J.E.2
Kreiss, J.K.3
Ndinva-Achola, J.O.4
Braddick, M.5
Temmerman, M.6
-
12
-
-
0032558333
-
International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection
-
For data on late postnatal transmission see also Leroy V, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet 1998; 352:597-600.
-
(1998)
Lancet
, vol.352
, pp. 597-600
-
-
Leroy, V.1
-
14
-
-
0003530162
-
-
Investing in health. Washington DC: World Bank
-
World Bank. World development report 1993. Investing in health. Washington DC: World Bank, 1993, and: World Health Organisation. Investing in health research and development. Report of the ad hoc committee on health research related to future intervention options. Geneva: World Health Organisation, 1996.
-
(1993)
World Development Report 1993
-
-
-
16
-
-
34548194623
-
A positive response to perinatal HIV
-
See, for example: Anonymous [editorial]. A positive response to perinatal HIV. Lancet 1999;353:511.
-
(1999)
Lancet
, vol.353
, pp. 511
-
-
|